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Abstract
Introduction Death is the permanent cessation of the critical functions of the organism as a whole. However, the shutdown 
of a complex biological organism does not abruptly terminate at time of death. New high-throughput technologies allow the 
systematic investigation of the biochemical modulations occurring after death. Recent genomics studies have demonstrated 
that genes remain active after death, triggering upregulation of some genes and initiating feedback loops. These genes were 
mostly involved in pathways related to immunity, inflammation and cancer. These genetic modulations suggest many bio-
chemical events persist after death, which can be captured using a metabolomics approach.
Objectives This proof of concept work aimed to determine whether NMR spectroscopy could identify metabolomics changes 
occurring after death, and characterise the nature of these metabolomics modulations.
Methods High-resolution 1H-NMR spectroscopy was applied to six biological matrices: heart, kidney, liver, spleen, skin 
and white adipose tissue of ten adult mice at three different type points.
Results Forty-three metabolites were associated with post mortem metabolomics modulations. Kidney, heart and spleen 
showed the highest metabolic perturbations. Conversely, skin and white adipose tissue were the least altered matrices. Early 
metabolic modulations were associated with energy metabolism and DNA synthesis, by contrast, late metabolomics modula-
tions were associated with microbial metabolism.
Conclusions NMR has proven potential to determine the time of death based on post-mortem metabolomics modulations. 
This could be useful in the context of transplants, forensic studies and as internal quality control in metabolomics studies. 
Further investigations are required to validate these findings in humans in order to determine which compounds robustly 
reflect post-mortem metabolic fluctuations to accurately determine the time of death.
Keywords Post-mortem metabolome · Nuclear magnetic resonance spectroscopy (NMR) · Biomarkers · Forensic research
Abbreviations
NMR  Nuclear magnetic resonance
TP  Time point
1 Introduction
The definition of death, the end of the life of an organism, 
has evolved along history as technology has progressed, 
from a simple cardiorespiratory centred concept to a mod-
ern neurocentric diagnosis (Laureys 2005). Nowadays, the 
most accepted description of death is “permanent cessation 
of the critical functions of the organism as a whole” (Bernat 
1998). However, not all the functions cease simultaneously, 
and the shutdown of a complex biological organism, such as 
a human being, does not abruptly terminate at time of death 
(Pozhitkov et al. 2016).
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The shutting down of an individual, consequent disas-
sembly and biochemical pathways involved, have been lit-
tle investigated so far, but the advent of new high-through-
put technologies brings in new possibilities in the area of 
genetic, epigenetic, proteomic and metabolomics. A better 
understanding of biochemical events occurring after death 
is critical to maximize the success of organ transplantation, 
cancer research and may contribute to criminal investiga-
tions (Mitch 2016).
During a forensic investigation, the estimation of the post-
mortem interval (PMI) is normally based on factors such as 
the body’s core temperature, livor mortis, rigor mortis or 
other evidence external to the body itself, such as the time 
when the last registered phone activity occurred. In order 
to accurately evaluate the time of death, various chemical 
methods have been established since the early 1970s’ using 
samples from liver, skeletal muscle, vitreous humour, cer-
ebrospinal fluid and serum. However, the precise estimation 
of the PMI remains a challenge (Mitch 2016; Ith et al. 2002; 
Coe 1974; Endo et al. 1990; Muñoz et al. 2001; Bocaz-Ben-
eventi et al. 2002; Mittmeyer and Welte 1982; Bonte 1975).
Preliminary genetic studies have shown in deceased 
humans, mice and zebrafish models, that some genes remain 
active up to four days after death. Not only were these genes 
active, but they also upregulated or initiated feedback 
loops including upregulation of immunity, inflammation 
and cancer genes within one hour from death. It has also 
been hypothesized by Pozhitkov and colleagues (2016) that 
immune reaction against some transplanted organs could be 
linked to the genetic activity of the organ itself, rather than 
to immunosuppressive agents (Aberg et al. 2008; Haagsma 
et al. 2001). It was suggested that the risk of suffering a can-
cer post organ transplantation is associated with pro- onco-
genic genes expressed after death (Burra and Rodriguez-
Castro 2015; Pozhitkov et al. 2016; Schrem et al. 2016). 
Increase in transcript abundance after death was attributed to 
thermodynamics and kinetic dynamics including epigenetic 
changes (Pozhitkov et al. 2016). These processes have been 
hypothesised to be linked with changes in the wrapping of 
the nucleosome, nucleopores and ion/solute protein chan-
nels (Mattson and Chan 2003; Lang et al. 2005; Pozhitkov 
et al. 2016).
Consistent with Pozhitkov and colleagues’s findings, pre-
vious studies in human cadavers, using reverse transcrip-
tion real-time quantitative PCR (RT-RT qPCR), also showed 
active post-mortem activity resulting in gene upregulation 
twelve hours after death affecting myosin light chain 3 
(Myl3), vascular endothelial growth factor A (Vegfa) and 
matrix metalloprotease 9 (Mmp9) genes (González-Herrera 
et  al. 2013). This suggests that significant biochemical 
modulations occur after death, which may be informative 
to determine PMI.
Metabolomics is an established method to study the 
metabolome of an organism using high-resolution untar-
geted spectroscopy approaches such as nuclear magnetic 
resonance (NMR) spectroscopy and mass spectrometry 
(MS) (Daviss 2005; Nicholson 2006; Nicholson et al. 1999; 
Klug et al. 2012; Bernot 2004; Blackstock and Weir 1999). 
A similar approach has been applied to study post-mortem 
samples of brain from sheep and selected human samples 
(Ith et al. 2002) using 1H magnetic resonance spectroscopy 
(1H-MRS), and the rat retina by gas chromatography-mass 
spectrometry (GC-MS) and ultra high performance liquid 
chromatography-mass spectrometry (UHPLC-MS) (Tan 
et al. 2016). 1H-NMR has been applied to identify post-
mortem changes in food appropriately preserved for human 
consumption such as salmon, chicken and beef (Shumilina 
et al. 2015; Schreurs 2000; Graham et al. 2010).
Many animals such as pigs, humans, rodents, chickens, 
and horse have been metabolically characterised by 1H 
NMR spectroscopy in the recent past (Claus et al. 2008; Le 
Roy et al. 2016; Martin et al. 2007; Merrifield et al. 2011; 
Ndagijimana et al. 2009; Holmes et al. 1997; Escalona et al. 
2015), but to the best of our knowledge, there is no exhaus-
tive metabolomics 1H NMR-based characterisation of post-
mortem changes.
A better understanding of molecular changes occur-
ring after death would help in transplantation and cancer 
research, forensic sciences and as quality control for metabo-
lomics analyses. Thus, the aim of this study was to charac-
terise which metabolomics changes occur after death, and 
whether or not NMR spectroscopy could identify metabo-
lomics modulations between three post-mortem time points 
in different tissues from a common rodent model.
2  Materials and methods
2.1  Animal design
Ten 4-week-old C57BLKS db/+ mice (females, n = 6; males, 
n = 4) were acquired from Taconic Bioscience. Bedding was 
mixed between cages to minimise cage effect due to varia-
tions in the microbial environment on a weekly basis. Mice 
were humanly euthanized by neck dislocation, according to 
the specifications of the United Kingdom Animals Scientific 
Procedures Act, 1986 (ASPA) when they were one year old. 
None of these animals displayed any sign of illness and they 
were assumed to be healthy at the time of death. Animal pro-
cedures were conducted according to the UK ethical legisla-
tion on animal experimentation (ASPA 1986) and approved 
by the Home Office (PPL 70/7942).
Bodies were kept at room temperature until time of dis-
section immediately after euthanasia (Time Point 1, n = 3), 
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six hours after euthanasia (Time Point 2, n = 3) and 24 h 
after euthanasia (Time Point 3, n = 4).
Heart, kidney, liver, spleen, skin and White Adipose Tis-
sue (WAT) were collected and immediately frozen in liquid 
nitrogen and kept at − 80 °C until analysis.
2.2  Sample preparation
Tissue biopsies (~ 70 mg) were cut on a frozen surface to 
prevent metabolic degradation. Samples were homogenised 
into closed sterile microtubes with 1 mL methanol/water 
(1:1) using a Tissue Lyser LT (Qiagen, Germany) and 
1 mm diameter zirconia beads. In the case of WAT samples, 
0.5 mL of methanol/water (3:1) added to 0.3 mL of Chlo-
roform were used to separate lipids from the polar phase. 
The homogenate was then centrifuged at 5000×g for 5 min 
at 4 °C. The supernatants of these centrifugation products 
were evaporated in a speed vacuum concentrator (Eppen-
dorf, Germany) at 30 °C for 4 h. These polar extracts were 
reconstituted in 200 µL of phosphate buffer and transferred 
into 3 mm NMR tubes with code. Samples were kept in 
a SampleJet (Bruker Biopsin, Rheinstetten, Germany) at 
5.8 ± 0.1 °C until 1H NMR acquisition at 25 °C. The acqui-
sition time per sample was 15 min.
2.3  NMR analysis
A Bruker Avance HD 700 MHz (Bruker Biopsin, Rhein-
stetten, Germany) equipped with a cooled SampleJet and 
a TCI CryoProbe from the same manufacturer was used to 
acquire the spectra from all biofluids. The data was recorded 
at 25 °C ± 0.15 °C calibrated with a Methanol-D4 sample 
(Findeisen et al. 2007).
One-dimensional 1H NMR-based experiment, Carr-Pur-
cell-Meiboom-Gill (CPMG) (Meiboom and Gill 1958), was 
recorded with presaturation applied for 3 s during the relaxa-
tion delay at a  B1 field of 50 Hz, 64 scans, 8 dummy scans 
and 32 k complex pairs over a spectral width of 9091 Hz. 
CPMG  T2 filter was set at 39 ms (122 echoes of 316 µs).
2.4  Data processing and statistical analysis
MestReNova version 11.0.2-18153 (Mestrelab Research 
S.L., Spain) was used to pre-process spectra. Manual phase 
Fig. 1  Heart: a Time point 1 versus time point 2. Score and loading plots from the O-PLS DA model (n = 6). b Time point 1 versus time point 3. 
Score and loading and plot from the O-PLS DA model (n = 7). c Time point 2 versus time point 3. Score and loading plots the O-PLS DA (n = 7)
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correction and automatic baseline correction were per-
formed using the Whittaker Smoother algorithm. Calibra-
tions were carried out using TSP (δ 0.00 ppm). Residual 
water (δ 4.70 ppm − 5.10 ppm) and noise (regions before δ 
0.5 ppm and after δ 9.5 ppm) were removed before exporting 
spectra for statistical analysis.
Matlab version R2015b (Mathworks, UK) was used 
to carry out the statistical analysis using algorithms pro-
vided by the Korrigan Toolbox version 0.1 (Korrigan Sci-
ences Ltd., U.K.). After normalisation using a median-base 
probabilistic quotient method (Dieterle et al. 2006) sample 
variability was evaluated using an unsupervised Principal 
Component Analysis (PCA). Supervised pairwise Orthogo-
nal Projection to Latent Structures Discriminant Analysis 
(O-PLS DA) was used to identify metabolomics modula-
tions associated with the time of death. Seven-fold cross-
validation was used to evaluate the goodness of prediction 
(Q2Y value) of the O-PLS DA models. The scores are shown 
as a plot of the model scores (T) on the x axis against the 
cross-validated scores (Tcv) on the y axis. This allows to 
visualise the level of overfit since overfitted models would 
scatter away from the diagonal. The model loadings plot 
was colour-coded to display metabolites that are strongly 
associated with the discriminant component in warm col-
ours (colours close to red); by contrast, metabolites in cold 
colours (colours close to blue) are not discriminant.
Chenomx NMR Suite 8.2 from Chenomx Inc (Edmonton, 
Canada), The Human Metabolome Database (http://www.
hmdb.ca) and available literature (Claus et al. 2011, 2008; de 
Castro et al. 2013; Le Roy et al. 2016) were used for metabo-
lite identification. This pipeline is a standard method in the 
field and has been previously employed by our group and 
other groups (Castro et al. 2013; Le Roy et al. 2016; Claus 
et al. 2011, 2008; Giallourou et al. 2018) as being considered 
an acceptable NMR data analysis approach.
3  Results
Determination of time of death still represent a challenge 
for the scientific community. In this investigation, we com-
bined NMR metabolic profiling with multivariate statistics 
Fig. 2  Kidney: a Time point 1 versus time point 2. Score and load-
ing plots from the O-PLS DA model (n = 6). b Time point 1 versus 
time point 3. Score and loading and plot from the O-PLS DA model 
(n = 7). c Time point 2 versus time point 3. Score and loading plots 
the O-PLS DA (n = 7)
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to evaluate sequential metabolic modulations after death. 
Principal Component Analyses (PCA) were carried out on 
all datasets to evaluate sample variability. Specific meta-
bolic modulations were more accurately evaluated using 
pairwise supervised O-PLS DA analyses comparing Time 
Point 1 (immediately after euthanasia), Time Point 2 (six 
hours after euthanasia) and Time Point 3 (twenty-four hours 
after euthanasia).
Heart was one of the tissues that underwent the most 
metabolic modulations after death. In total, 65 metabolic 
modulations occurred when comparing the three-different 
time points. These modulations were evenly distributed 
between the three possible pairwise comparisons. In the 
comparison between TP1 versus TP2 (n = 6,  R2Y = 0.94, 
 Q2Y = 0.60, Fig. 1a) inosine and ATP were the two metab-
olites that were drastically decreased in TP2 compared to 
TP1; by contrast, glycerol and malonate were higher in 
TP2 than in TP1. TP3 compared to TP1 (n = 7,  R2Y = 0.97, 
 Q2Y = 0.71, Fig. 1b) had significantly higher levels of 
phenylalanine and some branched chain amino acids. 
Conversely, TP3 had lower levels of niacinamide, energy 
transporters such as IMP and ATP, and inosine. Finally, 
the comparison between TP2 and TP3 (n = 7,  R2Y = 0.96, 
 Q2Y = 0.44, Fig. 1c) showed that the main differences 
driving the model came from the increase of adenine and 
niacinamide in TP3. Other metabolites fluctuating between 
these time points are reported in Fig. 1 and Supplementary 
material S1.
Kidney was another tissue showing numerous metabolic 
alterations after death reflected by a total of 70 metabolic 
fluctuations. Metabolomics differences occurring in kid-
ney after death principally included lower levels of inosine 
and higher levels of lactate in TP2 compared to TP1 (n = 6, 
 R2Y = 0.95,  Q2Y = 0.61, Fig. 2a). In the model comparing 
TP1 and TP3 (n = 7,  R2Y = 0.99,  Q2Y = 0.87, Fig. 2b), dif-
ferences were due to significantly lower levels of inosine, 
uracil and taurine. TP3 by contrast had higher levels of phe-
nylalanine and tyrosine. Accordingly, metabolic differences 
observed in kidney tissue between TP2 and TP3 included 
lower levels of inosine, niacinamide and adenine and signifi-
cantly higher levels of phenylalanine and tyrosine in TP3. 
More details about metabolic fluctuations between different 
time points are provided in Fig. 2 and Supplementary mate-
rial S1.
The liver, unlike the previous organs, displayed only 34 
metabolic differences in total, which indicates that this organ 
has some resistance to metabolic degradation after death. 
Differences between TP1 and TP2 were mainly characterised 
Fig. 3  Liver: a Time point 1 versus time point 2. Score and loading plots from the O-PLS DA model (n = 6). b Time point 1 versus time point 3. 
Score and loading and plot from the O-PLS DA model (n = 7). c Time point 2 versus time point 3. Score and loading plots the O-PLS DA (n = 7)
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by a decrease of maltose and glutamate in TP2 compared 
to TP1, and an increase of acetate which is a sign of deg-
radation for acetyl-coA which cannot enter the Krebs cycle 
in the mitochondria anymore due to lack of oxygen (n = 6, 
 R2Y = 0.84,  Q2Y = 0.64, Fig. 3a). TP3 showed significantly 
higher levels of creatine compared to TP1, while glu-
tathione levels were drastically decreased (n = 7,  R2Y = 0.89, 
 Q2Y = 0.65, Fig. 3b). Finally, TP3 also showed higher levels 
of maltose and creatine, and had slightly lower levels of 
glucose than TP2 (n = 7,  R2Y = 0.83,  Q2Y = 0.50, Fig. 3c).
The organ showing the highest number of metabolic fluc-
tuations was spleen, that counted for 75 modulations in total 
between different time points. During the 6 h of lapse time 
between TP1 and TP2, lactate and acetate increased. Con-
versely, glucose, creatine and taurine significantly decreased 
six hours after death (n = 6,  R2Y = 0.87,  Q2Y = 0.68, Fig. 4a). 
When comparing TP1 and TP3, taurine, choline, inosine and 
adenine were significantly lower at TP3, while phenylala-
nine and tyrosine increased (n = 7,  R2Y = 0.98,  Q2Y = 0.88, 
Fig. 4b). Finally, the metabolic differences between TP2 and 
3 were represented by lower levels of taurine, choline and 
glutamate in TP3, and higher levels of creatine and pheny-
lalanine (n = 7,  R2Y = 0.97,  Q2Y = 0.70, Fig. 4c).
Skin samples showed little differences over time, counting 
only twenty-eight detectable metabolic modulations in total. 
These differences included for example higher levels of lac-
tate after 6 h from the time of death (TP2), which could be 
associated with bacterial activity, and lower levels of glucose 
and taurine (n = 6,  R2Y = 0.83,  Q2Y = 0.31, Fig. 5a). Differ-
ences between TP1 and TP3 were similar to the metabolic 
variations observed between TP1 and TP2, besides increased 
levels of creatine, phenylalanine, tyrosine and histamine (n = 7, 
 R2Y = 0.88,  Q2Y = 0.60, Fig. 5b) at TP3. The metabolic com-
parison between TP2 and TP3 showed lower levels of lac-
tate, fumarate and maltose and higher levels of phenylalanine, 
tyrosine and histamine at TP3 (n = 7,  R2Y = 0.80,  Q2Y = 0.21, 
Fig. 5c). All the metabolic fluctuations are summarised in the 
Supplementary material S1.
The metabolomics analysis of the polar phase of WAT 
showed that some metabolites including leucine, isoleucine 
and lactate were lower at TP2 compared to TP1; however, 
there were no significant metabolic increases after six hours 
(TP2) (n = 6,  R2Y = 0.95,  Q2Y = 0.80, Fig. 6a). TP3 com-
pared to TP1 had lower levels of lactate, myo-inositol and 
taurine; similarly to the previous model, no significant meta-
bolic increases were observed (n = 7,  R2Y = 0.80,  Q2Y = 0.47, 
Fig. 6b). Some metabolic fluctuations were observed between 
Fig. 4  Spleen: a Time point 1 versus time point 2. Score and load-
ing plots from the O-PLS DA model (n = 6). b Time point 1 versus 
time point 3. Score and loading and plot from the O-PLS DA model 
(n = 7). c Time point 2 versus time point 3. Score and loading plots 
the O-PLS DA (n = 7)
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TP3 and TP2, where the former had clearly higher levels of 
lactate and branched chain amino acids (n = 7,  R2Y = 0.95, 
 Q2Y = 0.83, Fig. 6c). More details about metabolic fluctua-
tions are provided in Supplementary material S1.
4  Discussion
1H NMR-based metabolomics fingerprinting has been 
previously used to characterised the metabolome of pigs, 
humans, rodent, chicken, horses and even the metabolomics 
changes occurring in diseases such as Type 2 Diabetes in a 
rodent model (Claus et al. 2008; Le Roy et al. 2016; Martin 
et al. 2007; Merrifield et al. 2011; Ndagijimana et al. 2009; 
Holmes et al. 1997; Escalona et al. 2015; Mora-Ortiz et al. 
2018). However, to date, little metabolomic approaches have 
been used to characterise PM biochemical modulations. Pre-
viously, PM analysis were based on temperature, the golden 
standard being the Henssge nomogram method (based on 
the two-exponential model of body cooling). Other com-
plementary methods are the compound method, which uses 
the skeletal muscle electrical and mechanical excitability, 
post-mortem lividity, rigor mortis and pharmacological 
excitability of the iris (Medea 2016).
The present study is a proof of concept work that aimed to 
determine whether NMR-based metabolomics has potential 
to distinguish biochemical changes at different time points 
after death. Results show that 43 metabolites have been 
linked to PM changes overtime, the kidney and spleen being 
the two organs that showed the highest modulations, and 
skin the organ showing the least metabolic fluctuations. This 
may be due to oxygen permeation through the skin (Stücker 
et al. 2002), which may delay the activation of anaerobic 
pathways in this tissue. Some of the metabolites that were 
more frequently associated with PM metabolic fluctuations 
included taurine, niacinamide, phenylalanine, tyrosine, glyc-
erol, xanthine and lactate.
Lactate was a metabolite often found modulated in differ-
ent matrices. When little amounts of oxygen are available, 
the anaerobic glycolysis of glucose reserves directs pyru-
vate to lactate production instead of entering the Krebs cycle 
under normal aerobic conditions (Supplementary material 
Fig. 5  Skin a Time point 1 versus time point 2. Score and loading plots from the O-PLS DA model (n = 6). b Time point 1 versus time point 3. 
Score and loading and plot from the O-PLS DA model (n = 7). c Time point 2 versus time point 3. Score and loading plots the O-PLS DA (n = 7)
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S2). As a consequence, lactate is known to accumulate in 
anaerobic conditions (Simchowitz and Textor 1992; Chen 
et al. 2017). In mammals, lactate can be recycled into glu-
cose in the liver, which is likely the reason why this organ 
does not show fluctuations in this metabolite unlike heart, 
kidney and spleen for example (Cox and Nelson 2008). To 
the contrary, WAT metabolic profiles contained lower lev-
els of lactate in TP2 and TP3 than in TP1. The WAT is 
an important contributor to circulating lactate levels (DiGi-
rolamo et al. 1992). Therefore, decreased lactate levels in the 
WAT may be resulting from the shuttle of lactate towards 
remote organs during anoxia (Brooks 2009; Gladden 2004). 
This lactate shuttle has been associated with gene expres-
sion involved in lactate removal (Gladden 2008; Hashimoto 
and Brooks 2008; Brooks 2009), which means that in a PM 
context lactate may support gene transcription as previously 
described by Pozhitkov and colleagues (2016). Other metab-
olites derived from energy metabolism pathways, like glyc-
erol that results mostly from lipolysis (Nielsen et al. 2014), 
were modulated in organs such as the spleen.
The purine degradation pathway produced several metab-
olites (IMP, Inosine, Hypoxanthine and Xanthine) identified 
in various organs such as the liver, heart and spleen (Al-Kha-
lidi and Chaglassian 1965). Since end-product metabolites 
from this pathway, such as allantoin, were not modulated, 
further nucleic acid degradation is likely to occur beyond 
twenty-four hours PM. Further metabolomics studies should 
consider a longer lapse of time to capture the end point of 
the purine degradation pathway. Other molecules such as 
taurine, betaine and myo-inositol, modulated in almost every 
organ, are associated with osmoregulation (Trachtman et al. 
1988; Burg and Ferraris 2008).
Niacinamide was also found modulated in several organs 
in this study. This is consistent with a previous report in the 
literature that linked it to PM processes in salmons (Shu-
milina et al. 2015). Other metabolites, such as phenylala-
nine and tyrosine may result from proteolysis but have also 
been associated with microbial activity in living organisms 
(Davila et al. 2013; Neis et al. 2015).
Fig. 6  WAT: a Time point 1 versus time point 2. Score and loading plots from the O-PLS DA model (n = 6). b Time point 1 versus time point 3. 
Score and loading and plot from the O-PLS DA model (n = 7). c Time point 2 versus time point 3. Score and loading plots the O-PLS DA (n = 7)
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This proof-of-concept work shows the potential of NMR 
metabolomics in a new field: Thanatometabolomics. Mass-
Spectrometry could also be explored as a potential alterna-
tive to study PM metabolomic changes. In further investiga-
tions, differences between sex and environmental conditions 
should be considered, which would require a higher number 
of individuals.
Interestingly, recent studies have suggested that the study 
of the thanatomicrobiome could be used by forensic micro-
biologists to estimate the time of death (Javan et al. 2016a, 
b; Can et al. 2014). This, along with thanotometabolomics 
and thanatotranscriptomics could provide new forensic tools 
for the prediction of the time of death.
5  Conclusion
To the best of our knowledge, this proof of concept study 
represents the largest metabolomics characterisation of 
post-mortem metabolic modulations. Kidney and spleen 
were the organs that displayed the largest metabolic modu-
lations over the 3 time-points investigated. The reported 
metabolic perturbations are consistent with anaerobic 
metabolism and show molecular mechanisms of compen-
sation for the lack of oxygen at the cellular level. Yet, 
further studies are required to validate the use of these 
potential biomarkers in humans. These should consider the 
impact of temperature, gender and environmental condi-
tions in the metabolic fluctuations occurring after death. 
Integration of thanatometabolomics with other omics’ 
technologies such as thanatomicrobiology and thanatotran-
scriptomics would also likely contribute to refine predic-
tion of the time of death.
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